Invega Hafyera 1,092 mg/3.5 mL injection Images
Generic Name: paliperidone
This medication has been identified as Invega Hafyera 1,092 mg/3.5 mL injection. It is supplied by Janssen Pharmaceuticals, Inc.
Invega Hafyera is used in the treatment of Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Invega Hafyera 1,092 mg/3.5 mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Invega Hafyera
- Generic Name
- paliperidone
- Strength
- 1,092 mg/3.5 mL injection
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 50458-0611
More about Invega Hafyera (paliperidone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
- En español
Patient resources
Other brands
Invega, Invega Sustenna, Invega Trinza
Professional resources
Other brands
Invega, Invega Sustenna, Invega Trinza
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
